Understanding food noise - and how to turn down the volume
Remedies for motion sickness: What works?
4 keys to a heart-healthy diet
Understanding exercise heart rate zones
Resistant starch: Can you make the carbs you eat a little healthier?
Harvard study: A couple of daily cups of coffee or tea linked to lower dementia risk
Does everyone benefit from cutting saturated fat in their diet?
How to treat shoulder impingement
Beyond protein: 6 other nutrients that help prevent muscle loss
Advancements in knee replacement: More precise and personalized
Adam S. Cheifetz, MD
Contributor
Dr. Adam Cheifetz is director of the center for inflammatory bowel disease and medical director of infusion services at Beth Israel Deaconess Medical Center, and professor of medicine at Harvard Medical School. He is a well-recognized leader in the treatment of Crohn’s disease, ulcerative colitis, and other inflammatory bowel diseases. He is involved in multiple research projects relating to IBD, and has published over 200 articles and chapters on the subject.
His research currently focuses on therapeutic drug monitoring and optimizing the use of biologics through the proactive use of drug concentrations and antibodies, and he has published extensively in this area. Dr. Cheifetz was the first to demonstrate that proactive monitoring of infliximab and adalimumab concentrations and dosing to a therapeutic window improves outcomes when compared to standard of care.
Understanding food noise - and how to turn down the volume
Remedies for motion sickness: What works?
4 keys to a heart-healthy diet
Understanding exercise heart rate zones
Resistant starch: Can you make the carbs you eat a little healthier?
Harvard study: A couple of daily cups of coffee or tea linked to lower dementia risk
Does everyone benefit from cutting saturated fat in their diet?
How to treat shoulder impingement
Beyond protein: 6 other nutrients that help prevent muscle loss
Advancements in knee replacement: More precise and personalized
